« Previous
Next »
Titles
- S11 nonclinical safety testing in support of development of pediatric pharmaceuticals1
- S5(R3) detection of reproductive and developmental toxicity for human pharmaceuticals1
- SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program1
- Sacramento area: large health systems grow in a pricey and tumultuous market1
- Safely, effectively reducing C-section rates: Sutter Health : Sacramento, Calif1
- Safer technologies program for medical devices: guidance for industry and Food and Drug Administration staff1
- Safety net hospitals in the Covid-19 crisis: how five hospitals have fared financially1
- Safety testing of drug metabolites1
- Same-day billing for medical and mental health services at FQHCs: estimating the fiscal impact1
- San Diego: competing, collaborating, and forging ahead with population health1
- San Francisco Bay Area: regional health systems vie for market share1
- San Joaquin Valley: despite poverty and capacity constraints, health care access improves1
- Scheduling uncertainty and employment of young adults with disabilities1
- Science & tech spotlight: social distancing during pandemics1
- Science & tech spotlight: vaccine safety1
- Science and tech spotlight: COVID-19 testing1
- Science and tech spotlight: COVID-19 vaccine development1
- Science and tech spotlight: CRISPR gene editing1
- Science and tech spotlight: coronaviruses1
- Science and tech spotlight: e-cirgarettes1